Get the Stockscreener App
1.28
0.00%
0.00
After Hours:
1.28
Heron Therapeutics Inc stock is traded at $1.28, with a volume of 898.90K.
It is up +0.00% in the last 24 hours and up +14.29% over the past month.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
See More
Previous Close:
$1.28
Open:
$1.28
24h Volume:
898.90K
Relative Volume:
0.48
Market Cap:
$234.70M
Revenue:
$137.74M
Net Income/Loss:
$-27.97M
P/E Ratio:
-8.00
EPS:
-0.16
Net Cash Flow:
$-9.61M
1W Performance:
-1.54%
1M Performance:
+14.29%
6M Performance:
-40.74%
1Y Performance:
-20.00%
1-Day Range:
$1.27
$1.31
1-Week Range:
$1.265
$1.40
52-Week Range:
$0.9999
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
Name
Heron Therapeutics Inc
Sector
Industry
Phone
(858) 251-4400
Address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Compare HRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.28 | 234.70M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.90 | 117.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.97 | 82.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.59 | 52.94B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
844.92 | 52.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.88 | 37.84B | 447.02M | -1.18B | -906.14M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-25 | Initiated | H.C. Wainwright | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-23-24 | Initiated | CapitalOne | Overweight |
| Mar-13-24 | Reiterated | Needham | Buy |
| May-27-20 | Initiated | Guggenheim | Buy |
| Feb-20-20 | Reiterated | Needham | Buy |
| Jan-16-19 | Reiterated | Needham | Buy |
| Apr-05-18 | Initiated | Evercore ISI | Outperform |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Mar-01-18 | Reiterated | Needham | Buy |
| Jan-03-18 | Initiated | Leerink Partners | Outperform |
| Sep-27-17 | Initiated | Northland Capital | Outperform |
| Feb-27-17 | Initiated | Needham | Buy |
| Oct-26-16 | Initiated | Aegis Capital | Buy |
| Sep-06-16 | Resumed | Lake Street | Buy |
| May-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Dec-10-15 | Initiated | Lake Street | Buy |
| Sep-23-15 | Reiterated | Leerink Partners | Outperform |
| Sep-02-15 | Initiated | BofA/Merrill | Buy |
| Aug-03-15 | Reiterated | Brean Capital | Buy |
| Jun-30-15 | Reiterated | JMP Securities | Mkt Outperform |
| Jun-19-15 | Reiterated | Leerink Partners | Outperform |
| Aug-07-14 | Initiated | Noble Financial | Buy |
View All
Heron Therapeutics Inc Stock (HRTX) Latest News
Exit Recap: Does Heron Therapeutics Inc stock trade at a discount to peers2025 Market WrapUp & Verified Momentum Watchlists - moha.gov.vn
What analysts say about Heron Therapeutics Inc AXD2 stockContrarian Investment Ideas & High Return Investment Growth - earlytimes.in
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Investor Mood: Will Heron Therapeutics Inc stock outperform tech sector in 2025Bear Alert & Long Hold Capital Preservation Tips - moha.gov.vn
Can Heron Therapeutics Inc. stock sustain market leadershipJuly 2025 Weekly Recap & Weekly Top Stock Performers List - Улправда
Is Heron Therapeutics Inc. stock attractive for income investorsJuly 2025 Highlights & Capital Protection Trading Alerts - Улправда
Can Heron Therapeutics Inc. stock surprise with earnings upsideJuly 2025 Spike Watch & Detailed Earnings Play Alerts - Улправда
How Heron Therapeutics Inc. stock reacts to global recession fearsWeekly Trend Recap & Community Consensus Picks - Улправда
How supply chain issues affect Heron Therapeutics Inc. stockJuly 2025 Movers & Daily Volume Surge Trade Alerts - Улправда
Is Heron Therapeutics Inc. stock cheap at current valuationJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - DonanımHaber
Can Heron Therapeutics Inc. stock sustain revenue growthJuly 2025 Review & Growth Focused Stock Reports - Улправда
How analysts rate Heron Therapeutics Inc. stock todayEarnings Risk Report & Expert Verified Stock Movement Alerts - DonanımHaber
Is Heron Therapeutics Inc. stock gaining market shareInflation Watch & Community Consensus Trade Alerts - Улправда
Will Heron Therapeutics Inc. stock gain from strong economyWeekly Earnings Recap & Real-Time Volume Surge Alerts - DonanımHaber
Heron Therapeutics Earnings Notes - Trefis
Congress Park Capital LLC Acquires 621,908 Shares of Heron Therapeutics, Inc. $HRTX - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) is favoured by institutional owners who hold 57% of the company - Yahoo Finance
Heron Therapeutics Appoints Thomas Cusack to Board - MSN
Heron Therapeutics Reports Strong Q3 2025 Revenue Growth - MSN
Heron Therapeutics Inc (HRTX) can make a big difference with a little luck - setenews.com
Heron Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Heron Therapeutics enters board agreement and completes refinancing transactions By Investing.com - Investing.com Nigeria
Activity Recap: Will Heron Therapeutics Inc stock deliver long term returnsDividend Hike & Weekly Market Pulse Updates - BỘ NỘI VỤ
San Diego Biotech Firm Heron Therapeutics Shifts Operations to North Carolina - MSN
What analysts say about Heron Therapeutics Inc stockGrowth Stock Opportunities & 5 Stocks Every Investor Should Own - earlytimes.in
Market Sentiment Around Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) - simplywall.st
Can Heron Therapeutics Inc. stock sustain institutional interestMarket Trend Report & High Return Trade Guides - Newser
Can Heron Therapeutics Inc. (AXD2) stock expand revenue streamsWeekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser
How cyclical is Heron Therapeutics Inc. (AXD2) stock compared to rivalsJuly 2025 Setups & Fast Entry High Yield Tips - Newser
Heron Therapeutics announces inclusion of Aponvie (aprepitant) - marketscreener.com
Heron Therapeutics Announces Inclusion of APONVIE® - GlobeNewswire
Why Heron Therapeutics Inc. stock attracts high net worth investorsWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Heron Therapeutics (Nasdaq: HRTX) APONVIE cited in fifth consensus PONV care guidelines - Stock Titan
Heron Therapeutics Injects New Life Into Growth Story With ZYNRELEF And APONVIE Momentum - RTTNews
Will Heron Therapeutics Inc. stock deliver long term returnsCPI Data & Risk Controlled Swing Trade Alerts - Newser
History Review: Can Heron Therapeutics Inc. stock sustain market leadershipJuly 2025 WrapUp & Daily Profit Focused Screening - BỘ NỘI VỤ
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives $4.50 Average Price Target from Brokerages - Defense World
Heron Therapeutics (HRTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What the Latest News Means for Eurotex Industries and Exports Limited Stock InvestorsProtective Put Strategies & Small Capital Trading Growth - earlytimes.in
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Trading Action: Can Heron Therapeutics Inc. stock surprise with earnings upsideQuarterly Trade Report & High Accuracy Swing Entry Alerts - moha.gov.vn
Heron Therapeutics, Inc. $HRTX Shares Sold by Orchard Capital Management LLC - MarketBeat
Jefferies Financial Group Inc. Acquires 344,200 Shares of Heron Therapeutics, Inc. $HRTX - MarketBeat
Is Heron Therapeutics Inc AXD2 a good long term investmentFundamental Strength Indicators & High Yield Stock Picks - earlytimes.in
Heron Therapeutics, Inc. (HRTX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Can Heron Therapeutics Inc. (AXD2) stock attract ESG investmentsJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Why Heron Therapeutics Inc. (AXD2) stock remains stableWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
How Heron Therapeutics Inc. (AXD2) stock responds to bond marketInsider Buying & AI Enhanced Trading Signals - newser.com
How Heron Therapeutics Inc. (AXD2) stock moves in volatile trading sessionsJuly 2025 Retail & Short-Term Trading Alerts - newser.com
Heron Therapeutics Inc Stock (HRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):